MedTrace Logo

Dose Finding Study to Assess Octenidine Mouthwash Concentrations in Comparison to Placebo

NCT02138552 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2014-05-14

No results posted yet for this study

Summary

The objective of this clinical trial is to identify the most efficacious octenidine dihydrochloride concentration regarding bacterial count reduction in comparison to a placebo in the oral cavity.

Conditions

  • Gingivitis

Interventions

DRUG

Octenidine dihydrochloride

Mouthrinsing - comparison of different dosages of Octenidine dihydrochloride over 4 days vs. Placebo

DRUG

Placebo

Mouthrinsing - comparison of different dosages of Octenidine dihydrochloride over 4 days vs. Placebo

Sponsors & Collaborators

  • Schülke & Mayr GmbH

    lead INDUSTRY

Principal Investigators

  • Katrin Lorenz, Dr. · Poliklinik für Parodontologie Med. Fakultät C. G. Carus der TU Dresden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02138552 on ClinicalTrials.gov